Celecoxib prevents malignant progression of smoking-induced lung tumors via suppression of the COX-2/PGE2 signaling pathway in mice

IntroductionLung cancer is characterized by a poor prognosis and is a significant comorbidity of chronic obstructive pulmonary disease (COPD). Therefore, effective chemopreventive agents are warranted. We evaluated the effects of the cyclooxygenase-2 (COX-2) inhibitor celecoxib on the prevention of...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Kaori Sakurai, Shotaro Chubachi, Jun Miyata, Junko Hamamoto, Tatsuro Naganuma, Takashi Shimada, Shiro Otake, Shingo Nakayama, Hidehiro Irie, Akihiro Tsutsumi, Naofumi Kameyama, Ahmed E. Hegab, Masayuki Shimoda, Hideki Terai, Hiroyuki Yasuda, Yae Kanai, Makoto Arita, Koichi Fukunaga
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2025-03-01
Ráidu:	Frontiers in Immunology
Fáttát:	chronic obstructive pulmonary disease lung neoplasms cyclooxygenase 2 inhibitor smoking prostaglandin E2 chemoprevention
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1557790/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!